AI Pilots And Strategic Partnerships

External manufacturing leaders are facing three interconnected challenges: adopting AI effectively, building genuine strategic partnerships with CDMOs, and navigating increasing geopolitical uncertainty. While AI is beginning to deliver measurable gains in areas such as supply chain modeling, demand planning, and technical documentation, many organizations continue to struggle with data quality, governance, and validation requirements.
At the same time, discussions around strategic partnerships reveal a gap between aspiration and reality. Strong relationships are defined not by labels, but by behaviors such as transparency, early collaboration, shared risk, and continuous improvement. Against a backdrop of tariffs, supply chain disruption, and regional manufacturing shifts, companies are also reassessing sourcing strategies and network resilience.
Drawing on insights from senior pharmaceutical and biotech leaders, the report highlights practical approaches to digital transformation, partnership management, and manufacturing network design in an increasingly complex global environment.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.